Russia is planning to develop a system of medical care to patients with hepatitis C and improve the mechanisms for funding such treatment on the basis of compulsory medical insurance (CHI). This is provided for in the action plan to combat the disease. The document was approved by Government Decree No. 3306-r dated November 2, 2022.
The plan is set to run until 2030, but most of the work will begin now.
- By the end of 2022, the Ministry of Health, together with the Compulsory Health Insurance Fund, will develop recommendations for the regions on the procedure of payment for medical care for patients with hepatitis C from CHI funds.
- At the beginning of 2023, federal and regional medical organizations have to switch to new differentiated payment rates for such treatment within compulsory medical insurance.
- At the beginning of 2023, a single register of patients with hepatitis C will be formed. This will help to clearly and promptly assess the amount of financial resources and medicines needed for patients.
- The Ministry of Industry and Trade and the Ministry of Health will provide ongoing assistance to pharmaceutical companies in the development of domestic production of such drugs.
- The Ministry of Health will have to analyze the best practices of treating patients with hepatitis C in federal and regional medical organizations in order to spread such practices to all clinics of the country.
- To improve the quality of medical care, the authorities provide for additional training for physicians treating patients with hepatitis C. It will begin in 2023 and continue on a regular basis as part of professional development and retraining programs.
Earlier, GxP News reported that Tatyana Golikova instructed the Ministry of Health, the Ministry of Industry and Trade, Rospotrebnadzor, Rosstandart, and the compulsory medical insurance fund (FOMS) to consider the plan prepared by the Central Office of the Government of the Russian Federation by September 10.